← Open Payments lookup

FRANK ABENANTE: Open Payments

NPI 1730273418 · MANAHAWKIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,294 in 104 payments from 12 companies in 2025. Trend: 2023 $25,059 · 2024 $20,833 · 2025 $6,294

Speaker / faculty: $4,500Food & beverage: $1,772Education: $23
CompanyPaymentsAmount
ABBVIE INC.13$4,770
Teva Pharmaceuticals USA, Inc.40$605
Otsuka America Pharmaceutical, Inc.14$252
Axsome Therapeutics, Inc.8$166
Neurocrine BioSciences, Inc.7$122
Bausch Health US, LLC5$81
Lundbeck LLC4$78
Alkermes, Inc.4$66
E.R. Squibb & Sons, L.L.C.4$63
IDORSIA PHARMACEUTICALS US INC2$40

Products named: VRAYLAR, AUSTEDO XR, REXULTI, Auvelity, INGREZZA, APLENZIN, ARISTADA, COBENFY.

Industry payments across NJ — which companies pay providers there.